Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL).
Saved in:
| Title: | Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL). |
|---|---|
| Authors: | Podgorica M; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Drivet E; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Vestbøstad J; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Kvam AK; Department of Haematology, Oslo University Hospital, Norway., Wik HS; Department of Haematology, Oslo University Hospital, Norway., Munthe L; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Schjerven H; Department of Immunology, Oslo University Hospital, and KG Jebsen Center for B-cell Malignancies, Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Norway.; Department of Laboratory Medicine, University of California San Francisco, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2311-2315. Date of Electronic Publication: 2025 Jul 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2536125 |
